Table 1.
Patients’ characteristics and medical history
| Characteristic | Patients, n (%) |
|---|---|
| Age, mean (SD), years | 51.7 (± 12.9) |
| Race | |
| White | 35 (59.3%) |
| Pardo | 20 (33.9%) |
| Yellow | 2 (3.4%) |
| Black | 2 (3.4%) |
| Reproductive status | |
| Postmenopause | 31 (52.5%) |
| Premenopause | 23 (39.0%) |
| Perimenopause | 4 (6.8%) |
| Unknown | 1 (1.7%) |
| Pre-existing medical condition | |
| Systemic arterial hypertension | 16 (27.1%) |
| Diabetes | 8 (13.6%) |
| Obesity | 13 (22.0%) |
| Dyslipidemia | 12 (20.3%) |
| Neoadjuvant chemotherapy | |
| No | 37 (62.7%) |
| Yes | 22 (37.3%) |
| Taxane | 10 (45.5%) |
| Anthracycline + taxane | 12 (54.5%) |
| Neoadjuvant anti-HER2 therapy | |
| No | 37 (62.7%) |
| Yes | 22 (37.3%) |
| Trastuzumab-dkst only | 4 (18.2%) |
| Trastuzumab-dkst + pertuzumab | 17 (77.3%) |
| Reference trastuzumab | 1 (4.5%) |
SD standard deviation